| Title: |
Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals ; ENEngelskEnglishAssociation between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals |
| Authors: |
Argote, Mathilde; Sescousse, Guillaume; Brunelin, Jérôme; Baudin, Grégoire; Schaub, Michael Patrick; Rabin, Rachel; Schnell, Thomas; Ringen, Petter Andreas; Andreassen, Ole; Addington, Jean Margaret; Brambilla, Paolo; Delvecchio, Giuseppe; Bechdolf, Andreas; Wobrock, Thomas; Schneider-Axmann, Thomas; Herzig, Daniela; Mohr, Christine; Vila-Badia, Regina; Rodie, Judith Usall; Mallet, Jasmina; Ricci, Valerio; Martinotti, Giovanni; Knížková, Karolína; Rodriguez, Mabel; Cookey, Jacob; Tibbo, Philip; Scheffler, Freda; Asmal, Laila; Garcia-Rizo, Clemente; Amoretti, Silvia; Huber, Christian; Thibeau, Heather; Kline, Emily; Fakra, Eric; Jardri, Renaud; Nourredine, Mikail; Rolland, Benjamin |
| Source: |
2589-5370. |
| Publisher Information: |
Elsevier |
| Publication Year: |
2023 |
| Subject Terms: |
psy; envir |
| Description: |
Background The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such as disorganization, depression, and excitement, have not been investigated. In addition, meta-analyses use aggregated data discarding important confounding variables which is a source of bias. Methods PubMed, ScienceDirect and PsycINFO were used to search for publications from inception to September 27, 2022. We contacted the authors of relevant studies to extract raw datasets and perform an Individual Participant Data meta-analysis (IPDMA). Inclusion criteria were: psychopathology of individuals with schizophrenia spectrum disorders assessed by the Positive and Negative Syndrome Scale (PANSS); cannabis-users had to either have a diagnosis of cannabis use disorder or use cannabis at least twice a week. The main outcomes were the PANSS subscores extracted via the 3-factor (positive, negative and general) and 5-factor (positive, negative, disorganization, depression, excitement) structures. Preregistration is accessible via Prospero: ID CRD42022329172. Findings Among the 1149 identified studies, 65 were eligible and 21 datasets were shared, totaling 3677 IPD and 3053 complete cases. The adjusted multivariate analysis revealed that relative to non-use, cannabis use was associated with higher severity of positive dimension (3-factor: Adjusted Mean Difference, aMD = 0.34, 95% Confidence Interval, CI = [0.03; 0.66]; 5-factor: aMD = 0.38, 95% CI = [0.08; 0.63]), lower severity of negative dimension (3-factor: aMD = −0.49, 95% CI [−0.90; −0.09]; 5-factor: aMD = −0.50, 95% CI = [−0.91; −0.08]), higher severity of excitement dimension (aMD = 0.16, 95% CI = [0.03; 0.28]). No association was found between cannabis use and disorganization (aMD = −0.13, 95% CI = [−0.42; 0.17]) or depression (aMD = −0.14, 95% CI = [−0.34; 0.06]). Interpretation No causal relationship can be inferred from ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
http://hdl.handle.net/10852/106083 |
| Availability: |
http://hdl.handle.net/10852/106083 |
| Rights: |
undefined |
| Accession Number: |
edsbas.D5CE4148 |
| Database: |
BASE |